Discover 4,544 paid clinical trials in New York State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
New York State presents a wide array of paid research opportunities for both healthy volunteers and those with specific health concerns. Actively recruiting research institutions in New York City, Buffalo, and Rochester offer access to innovative treatments and exceptional medical care near you.
Filter
1
Filter results
Results: 4,544
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
Location: New York NY, Baltimore MD, Grand Rapids MI
Sponsor: Leiden University Medical Center
Sex: All
Age: 18+
Code: NCT06932081
Recruiting
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
Location: New York NY, Harrisburg PA, Columbus OH, Atlanta GA,
Sponsor: CroiValve Limited
Sex: All
Age: 18+
Code: NCT05913908
Recruiting
A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer,
Location: New York NY, New Brunswick NJ, Tampa FL,
Sponsor: John Sfakianos
Sex: All
Age: 18+
Code: NCT06503614
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
for
SCLC
Location: New Haven CT, Hackensack NJ, Fairfax VA, Durham NC,
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06179069
Phase1, Recruiting
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
for
Hematuria - Cause Not Known
Location: New York NY, Poughkeepsie NY, Albany NY,
Sponsor: Pacific Edge Limited
Sex: All
Age: 18 - 70+
Code: NCT06394869
Recruiting
Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18+
Code: NCT05711446
Recruiting
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue